Acute Lymphoblastic Leukemia ALL
71
16
22
27
Key Insights
Highlights
Success Rate
79% trial completion
Published Results
16 trials with published results (23%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
9.9%
7 terminated out of 71 trials
79.4%
-7.1% vs benchmark
8%
6 trials in Phase 3/4
59%
16 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (71)
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT
Reduce Sedentary Time in Acute Lymphoblastic Leukemia
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
CAYA Cancer Prospective Cohort Study
Bio-CAR-T BS Study
Role of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.
Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders
Expanded Access to Venetoclax
Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
CAYA Cancer Retrospective Cohort Study